As of 11:37am ET
| -0.24 / -3.10%|
The 2 analysts offering 12-month price forecasts for Juniper Pharmaceuticals Inc have a median target of 11.50, with a high estimate of 14.00 and a low estimate of 9.00. The median estimate represents a +53.13% increase from the last price of 7.51.
The current consensus among 2 polled investment analysts is to Buy stock in Juniper Pharmaceuticals Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.